Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:PMC

Pharmerica (PMC) Stock Price, News & Analysis

Pharmerica logo

About Pharmerica Stock (NYSE:PMC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
283,015 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PMC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharmerica and its competitors with MarketBeat's FREE daily newsletter.

PMC Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Activities of Daily Living for Seniors
Golden Living
See More Headlines

PMC Stock Analysis - Frequently Asked Questions

Pharmerica Co. (NYSE:PMC) issued its quarterly earnings data on Thursday, November, 9th. The company reported $0.46 EPS for the quarter, missing analysts' consensus estimates of $0.49 by $0.03. The firm earned $595.10 million during the quarter, compared to analyst estimates of $596.80 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharmerica investors own include Cencora (COR), Capitol Federal Financial (CFFN), Bristol Myers Squibb (BMY), Tesla (TSLA), Depomed (DEPO), Inovio Pharmaceuticals (INO) and Bioblast Pharma (ORPN).

Company Calendar

Last Earnings
11/09/2017
Today
8/15/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Distributors
Current Symbol
NYSE:PMC
CIK
1388195
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:PMC) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners